No Data
No Data
Nurix Therapeutics Treatment of Waldenstrom Macroglobulinemia Gets Orphan Status
Press Release: Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
Some Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shareholders Look For Exit As Shares Take 28% Pounding
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $36
Benjamin Franklin 76 OP : thats the latest
blessings u : what time?